Indian Indices
Global Indices
Commodity (SPOT)
Currency (SPOT)
16 Jan 2017 | 6:41 PM
 

Bafna Pharmaceuticals Ltd. Share Price Live (BSE)
0

BSE Code: 532989 | NSE Symbol: BAFNAPHARM
32.10
0.00
(0.00 %)
16 Jan 2017 | 04:01 PM
Change company
  • Open (Rs)
    32.50
  • Prev. close (Rs.)
    32.10
  • High (Rs.)
    32.50
  • Low (Rs.)
    31.85
  • 52W H (Rs.)
    39.05
  • 52W L (Rs.)
    25.50
  • Volume (Rs.)
    4419
  • MCap (Rs in Cr.)
    59.89
No Data Available
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
-7.52
Operating Margin (%)
0.60
Gross Profit Margin (%)
-5.08
Net Profit Margin (%)
-16.44
Total Debt/Equity
1.39
Dividend payout Ratio (Net Profit)
0.00
Earning Retention Ratio
0.00

News

10 Jun 2015 - 11:12:00-Drug maker Bafna Pharmaceuticals Ltd on Wednesday said it has received the renewal certificate from ...
28 Oct 2014 - 11:15:00-Bafna Pharmaceuticals today said that it has appointed RS Gowdhaman as Company Secretary & Complianc...
26 Nov 2013 - 09:51:00-Shares of drug maker Bafna Pharmaceuticals rallied over 19 per cent in early trade on Bombay Stock E...
21 May 2013 - 15:06:00-Bafna Pharmaceuticals Ltd. has posted net loss of Rs 0...

Announcements

11-Jan-2017
Bafna Pharmaceutical - Calendar of events for Postal Ballot
11-Jan-2017
Bafna Pharmaceutical - Notice of Postal Ballot
10-Jan-2017
Bafna Pharmaceutical - Updates
10-Jan-2017
Bafna Pharmaceuticals Ltd. - Reply to Clarification Sought
09-Jan-2017
Bafna Pharmaceuticals Ltd. - Clarification

Religare Research

16 Jan 2017 | 07:00 AM
It was normal profit taking in index and stocks after the recent surge and it is healthy for the mar...
13 Jan 2017 | 06:00 PM
The company is a part of the century-old JK Organisation, one of India’s leading private sector ...
13 Jan 2017 | 06:00 PM
Nifty upheld bullish bias for the third consecutive week and settled after gaining nearly 2%. Among ...
13 Jan 2017 | 10:03 AM
The Indian rupee rose against the dollar, tracking gains in regional peers, as the greenback weakene...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
No Data Available

Shareholding Pattern

      
Promotors33.42%
Mutual Funds/UTI0.00%
FI/Banks0.08%
Insurance0.08%
FII0.00%
Government0.00%
Others8.87%

Peer Group

Company Intraday Graph
 Kovai Medical Center and Hospital Ltd.
1,030.00(0.03)
11816
 Neuland Laboratories Ltd.
1,006.00(-0.65)
3578
 Merck Ltd.
965.60(1.01)
3302
 AstraZeneca Pharma India Ltd.
952.00(-0.01)
3274

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Bafna Pharmaceuticals Ltd.1.80-0.200.95
NIFTY(S&P CNX)191.00-160.55-106.70
BSE SENSEX590.35-354.94-527.01
BSE 500315.30-278.34125.27

Corporate Details

Key Personal
B Kamlesh Kumar
Ind. Non-Executive Director
Bafna Mahaveer Chand
Chairman & Managing Director
K Sabitha
Non Ind.& Exe.Director
Key Address
Registered Office
Bafna Towers New?No.?68 ?Old?No. 299 ?? ? Thambu Chetty Street,Chennai (Madras),Tamil Nadu

Tel:044-25267517 42677555 25270992, Fax:044-25231264 42677599

info@bafnapharma.com
http://www.bafnapharma.com
Registrar Office
Cameo Corporate Services Ltd.
Add. :Subramanian Building No.1 Vth Floor Club House Road

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Bafna Pharmaceuticals Ltd. that will help you decide whether to buy, sell or hold Bafna Pharmaceuticals Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Bafna Pharmaceuticals Ltd.

Regenerate OTP
Thank You for your interest in Religare Online. Our Representative will get in touch with you shortly.